Orange Book product · Brand (NDA)
ACETAMINOPHEN
ACETAMINOPHEN
At a glance
Oct 28, 2015
Approved
Brand (NDA)
Application
Not listed
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 28, 2015
10 yr 10 mo ago
Today
Patent 8741959 expires
Listed drug product patent expiration.
Apr 19, 2030
in 3 yr 11 mo
Pharmaceutical detail
Active ingredient
ACETAMINOPHEN
Strength
1GM/100ML (10MG/ML)
Dosage form
SOLUTION
Route
INTRAVENOUS
TE code
Not listed
Application
NDA 204767
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- 2022ACETAMINOPHENBrand (NDA)
NDA 206968 · HIKMA
- 2021ACETAMINOPHENBrand (NDA)
NDA 204957 · B BRAUN MEDICAL
- 2021ACETAMINOPHENBrand (NDA)
NDA 206610 · RISING
- 2010OFIRMEVBrand (NDA)
NDA 022450 · MALLINCKRODT HOSP
- 1994TYLENOLBrand (NDA)
NDA 019872 · KENVUE BRANDS
- 1986INJECTAPAPBrand (NDA)
NDA 017785 · ORTHO MCNEIL PHARM
- 1983ACETAMINOPHENBrand (NDA)
NDA 018337 · TARO
- —ACEPHENBrand (NDA)
NDA 018060 · COSETTE
- —NEOPAPBrand (NDA)
NDA 016401 · POLYMEDICA
- —TYLENOLBrand (NDA)
NDA 017756 · J AND J CONSUMER INC
- 2025ACETAMINOPHENGeneric (ANDA)
ANDA 219096 · CAPLIN
- 2025ACETAMINOPHENGeneric (ANDA)
ANDA 219215 · GLAND
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8741959 | Apr 19, 2030 | in 3 yr 11 mo | Product |

